Multifaceted Spindle Cell/Sclerosing Rhabdomyosarcoma With Role of Immunohistochemistry in Avoiding Misdiagnosis : A Multi-Institutional Study of 45 Distinct Tumors
Background. Spindle cell/sclerosing rhabdomyosarcoma is a rare neoplasm and has an aggressive clinical course. Because of its rarity, we performed a multi-institutional collaboration to comprehend the overarching clinical, histopathological, and immunohistochemical characteristics of a cohort of spindle cell/sclerosing rhabdomyosarcoma. Materials and Methods. Forty-five patients with spindle cell/sclerosing rhabdomyosarcoma were identified. Demographics, clinical, histopathological, and immunohistochemistry data were reviewed and recorded. Results. The patients' age ranged from 1 to 85 years with a male to female ratio of 1.2:1. There were 15 children/adolescents and 30 adults. Eighteen (40%) tumors were located in the head and neck region. Twenty-four (53%) tumors displayed a bimorphic cellular arrangement with hypercellular areas having short, long, and sweeping fascicular and herringbone pattern, and hypocellular areas with stromal sclerosis and associated hyalinized and/or chondromyxoid matrix. Histomorphological differentials considered were leiomyosarcoma, malignant peripheral nerve sheath tumor, fibrosarcoma, nodular fasciitis, liposarcoma, synovial sarcoma, sarcomatoid carcinoma, solitary fibrous tumor, dermatofibrosarcoma protuberans, and schwannoma. Six tumors exhibited marked stromal sclerosis. The myogenic nature was confirmed by immunohistochemistry. Positivity for at least one skeletal muscle-associated marker (MyoD1 and/or myogenin) was observed. Conclusion. Spindle cell/sclerosing rhabdomyosarcoma diagnosis can be challenging as a number of malignant spindle cell neoplasm mimic this entity. Thus a correct diagnosis requires immunohistochemical work up with a broad panel of antibodies. In view of rarity of this neoplasm, further studies on a large cohort of patients with clinical follow-up data are needed for a better understanding of this tumor.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
International journal of surgical pathology - 32(2024), 3 vom: 02. Apr., Seite 496-506 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jain, Ekta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers, Tumor |
|---|
| Anmerkungen: |
Date Completed 18.04.2024 Date Revised 18.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/10668969231188422 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359894755 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359894755 | ||
| 003 | DE-627 | ||
| 005 | 20240418232246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/10668969231188422 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1379.xml |
| 035 | |a (DE-627)NLM359894755 | ||
| 035 | |a (NLM)37489265 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jain, Ekta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multifaceted Spindle Cell/Sclerosing Rhabdomyosarcoma With Role of Immunohistochemistry in Avoiding Misdiagnosis |b A Multi-Institutional Study of 45 Distinct Tumors |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.04.2024 | ||
| 500 | |a Date Revised 18.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background. Spindle cell/sclerosing rhabdomyosarcoma is a rare neoplasm and has an aggressive clinical course. Because of its rarity, we performed a multi-institutional collaboration to comprehend the overarching clinical, histopathological, and immunohistochemical characteristics of a cohort of spindle cell/sclerosing rhabdomyosarcoma. Materials and Methods. Forty-five patients with spindle cell/sclerosing rhabdomyosarcoma were identified. Demographics, clinical, histopathological, and immunohistochemistry data were reviewed and recorded. Results. The patients' age ranged from 1 to 85 years with a male to female ratio of 1.2:1. There were 15 children/adolescents and 30 adults. Eighteen (40%) tumors were located in the head and neck region. Twenty-four (53%) tumors displayed a bimorphic cellular arrangement with hypercellular areas having short, long, and sweeping fascicular and herringbone pattern, and hypocellular areas with stromal sclerosis and associated hyalinized and/or chondromyxoid matrix. Histomorphological differentials considered were leiomyosarcoma, malignant peripheral nerve sheath tumor, fibrosarcoma, nodular fasciitis, liposarcoma, synovial sarcoma, sarcomatoid carcinoma, solitary fibrous tumor, dermatofibrosarcoma protuberans, and schwannoma. Six tumors exhibited marked stromal sclerosis. The myogenic nature was confirmed by immunohistochemistry. Positivity for at least one skeletal muscle-associated marker (MyoD1 and/or myogenin) was observed. Conclusion. Spindle cell/sclerosing rhabdomyosarcoma diagnosis can be challenging as a number of malignant spindle cell neoplasm mimic this entity. Thus a correct diagnosis requires immunohistochemical work up with a broad panel of antibodies. In view of rarity of this neoplasm, further studies on a large cohort of patients with clinical follow-up data are needed for a better understanding of this tumor | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a MyoD1 | |
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a myogenin | |
| 650 | 4 | |a sclerosing rhabdomyosarcoma | |
| 650 | 4 | |a spindle cell rhabdomyosarcoma | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Munjal, Gauri |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Shivani |e verfasserin |4 aut | |
| 700 | 1 | |a Brar, Zoya |e verfasserin |4 aut | |
| 700 | 1 | |a Bhardwaj, Nitin |e verfasserin |4 aut | |
| 700 | 1 | |a Dewan, Aditi |e verfasserin |4 aut | |
| 700 | 1 | |a Jain, Deepika |e verfasserin |4 aut | |
| 700 | 1 | |a Jha, Shilpy |e verfasserin |4 aut | |
| 700 | 1 | |a Lobo, Anandi |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Vipra |e verfasserin |4 aut | |
| 700 | 1 | |a Arora, Samriti |e verfasserin |4 aut | |
| 700 | 1 | |a Varshney, Juhi |e verfasserin |4 aut | |
| 700 | 1 | |a Beg, Arshi |e verfasserin |4 aut | |
| 700 | 1 | |a Sampat, Nakul Y |e verfasserin |4 aut | |
| 700 | 1 | |a Parwani, Anil V |e verfasserin |4 aut | |
| 700 | 1 | |a Balzer, Bonnie |e verfasserin |4 aut | |
| 700 | 1 | |a Varma, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Brijpal S |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Shailendra K |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Hena Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Gogoi, Kamakhya |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Devendra |e verfasserin |4 aut | |
| 700 | 1 | |a Bhandari, Vijinder |e verfasserin |4 aut | |
| 700 | 1 | |a Fulara, Lalit M |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Arvind |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Harish |e verfasserin |4 aut | |
| 700 | 1 | |a Bhattacharya, Munmun |e verfasserin |4 aut | |
| 700 | 1 | |a Dixit, Mallika |e verfasserin |4 aut | |
| 700 | 1 | |a Mohanty, Sambit K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of surgical pathology |d 1997 |g 32(2024), 3 vom: 02. Apr., Seite 496-506 |w (DE-627)NLM092664202 |x 1940-2465 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2024 |g number:3 |g day:02 |g month:04 |g pages:496-506 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/10668969231188422 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2024 |e 3 |b 02 |c 04 |h 496-506 | ||